These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 791107)

  • 1. Effects of doxycycline in actively purging cholera patients: a double-blind clinical trial.
    Rahaman MM; Majid MA; Alam AKMJ ; Islam MR
    Antimicrob Agents Chemother; 1976 Oct; 10(4):610-2. PubMed ID: 791107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose treatment of cholera with furazolidone or tetracycline in a double-blind randomized trial.
    Rabbani GH; Islam MR; Butler T; Shahrier M; Alam K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1447-50. PubMed ID: 2684006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled comparison of single-dose ciprofloxacin and doxycycline for cholera caused by Vibrio cholerae 01 or 0139.
    Khan WA; Bennish ML; Seas C; Khan EH; Ronan A; Dhar U; Busch W; Salam MA
    Lancet; 1996 Aug; 348(9023):296-300. PubMed ID: 8709688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised double blind trial of single dose doxycycline for treating cholera in adults.
    Alam AN; Alam NH; Ahmed T; Sack DA
    BMJ; 1990 Jun; 300(6740):1619-21. PubMed ID: 2196962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative trial of tetracycline, chloramphenicol, and trimethoprim-sulphamethoxazole in eradication of Vibrio cholerae El Tor.
    Gharagozloo RA; Naficy K; Mouin M; Nassirzadeh MH; Yalda R
    Br Med J; 1970 Oct; 4(5730):281-2. PubMed ID: 4920226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single dose tetracycline in cholera.
    Islam MR
    Gut; 1987 Aug; 28(8):1029-32. PubMed ID: 3311904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxycycline in the treatment of cholera.
    De S; Chaudhuri A; Dutta P; Dutta D; De SP; Pal SC
    Bull World Health Organ; 1976; 54(2):177-9. PubMed ID: 1088099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetracycline in the treatment of severe cholera due to Vibrio cholerae O139 Bengal.
    Hossain MS; Salam MA; Rabbani GH; Kabir I; Biswas R; Mahalanabis D
    J Health Popul Nutr; 2002 Mar; 20(1):18-25. PubMed ID: 12022154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-dose doxycycline for cholera.
    Sack DA; Islam S; Rabbani H; Islam A
    Antimicrob Agents Chemother; 1978 Sep; 14(3):462-4. PubMed ID: 708024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled comparison of tetracycline and furazolidone in cholera.
    Pierce NF; Banwell JG; Mitra RC; Caranasos GJ; Keimowitz RI; Thomas J; Mondal A
    Br Med J; 1968 Aug; 3(5613):277-80. PubMed ID: 4873660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children.
    Roy SK; Islam A; Ali R; Islam KE; Khan RA; Ara SH; Saifuddin NM; Fuchs GJ
    Trans R Soc Trop Med Hyg; 1998; 92(4):460-2. PubMed ID: 9850410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative trial of five antimicrobial compounds in the treatment of cholera in adults.
    Khan WA; Begum M; Salam MA; Bardhan PK; Islam MR; Mahalanabis D
    Trans R Soc Trop Med Hyg; 1995; 89(1):103-6. PubMed ID: 7747291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.
    Morris JG; Losonsky GE; Johnson JA; Tacket CO; Nataro JP; Panigrahi P; Levin MM
    J Infect Dis; 1995 Apr; 171(4):903-8. PubMed ID: 7706818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-sulphamethoxazole in the treatment of cholera. Comparison with tetracycline and chloramphenicol.
    Pastore G; Rizzo G; Fera G; Schiraldi O
    Chemotherapy; 1977; 23(2):121-8. PubMed ID: 832549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae.
    Rabbani GH; Butler T; Knight J; Sanyal SC; Alam K
    J Infect Dis; 1987 May; 155(5):979-84. PubMed ID: 3549923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chemotherapy on the duration of diarrhoea, and on vibrio excretion by cholera patients.
    Francis TI; Lewis EA; Oyediran AB; Okubadejo OA; Montefiore D; Onyewotu II; Mohammed I; Ayoola EA; Vincent R
    J Trop Med Hyg; 1971 Aug; 74(8):172-6. PubMed ID: 4936576
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical studies of the use of bacteriophage in the treatment of cholera.
    Marcuk LM; Nikiforov VN; Scerbak JF; Levitov TA; Kotljarova RI; Naumsina MS; Davydov SU; Monsur KA; Rahman MA; Latif MA; Northrup RS; Cash RA; Hug I; Dey CR; Phillips RA
    Bull World Health Organ; 1971; 45(1):77-83. PubMed ID: 4946956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study to determine duration of vibrio cholerae excretion in Malawians and to test efficacy of treatment.
    Mkandawire AC
    Cent Afr J Med; 1981 Jul; 27(7):138-42. PubMed ID: 7307069
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind, randomized, controlled clinical trial of norfloxacin for cholera.
    Bhattacharya SK; Bhattacharya MK; Dutta P; Dutta D; De SP; Sikdar SN; Maitra A; Dutta A; Pal SC
    Antimicrob Agents Chemother; 1990 May; 34(5):939-40. PubMed ID: 2193628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid emergence of El Tor Vibrio cholerae resistant to antimicrobial agents during first six months of fourth cholera epidemic in Tanzania.
    Mhalu FS; Mmari PW; Ijumba J
    Lancet; 1979 Feb; 1(8112):345-7. PubMed ID: 85001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.